Home > Boards > US OTC > Medical - Drugs >

Inyx Inc. (IYXI)

Add IYXI Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/22/2021 1:13:47 PM - Followers: 28 - Board type: Free - Posts Today: 0

Inyx Inc. 825 Third Avenue 40th Floor New York, NY 10022 Phone: 212-838-1111 [img]www.secinfo.com/DB/SEC/2006-000/1144/204-0008/75-004.jpg[/img] [img]www.secinfo.com/DB/SEC/2006-000/1144/204-0132/54-002.jpg[/img] Outstanding Shares: 53,106,650 as of Aug 11, 2006 Tender Offer=3-25-07 by Chairman & CEO Jack Kachkar & a strategic outside investor to take the company private at $3.01 cash per sh. ... The troubles first kicked off for Inyx Inc.'s two UK units when on 28 June it was announced that they were forced into administration by Inyx Inc.'s financier Westernbank Puerto Rico, due to insolvency, i.e. they owed more money than they were capable of paying back, a reported $46m for Inyx Pharma and $54m for Ashton. Westernbank sent a letter to the two manufacturing firms, along with Inyx Europe, which is an intermediate holding company that owns and operates Ashton Pharma, alleging that the three firms "were in default under the loan and security agreements," it was reported in the Securities and Exchange Commission (SEC) filing at the time. In addition to the Chapter 11 protection, on June 29, 2007 , Inyx, Inc. and Inyx USA , together with Dr. Kachkar and his wife, filed suit against Westernbank in New York State Supreme Court , asserting various causes of action seeking no less that $500 million in compensatory damages as well as punitive damages. The complaint charges, among other things, that Westernbank acted in bad faith and in a commercially unreasonable manner by blocking the flow of funds from Inyx's customers to the company, and preventing the Inyx companies from paying their debts. The complaint asserts causes of action for breach of contract and breach of the implied covenant of good faith and fair dealing, promissory estoppel, wrongful dishonor of checks, wrongful impairment of collateral, tortious interference or impairment with prospective business relations, and third-party beneficiary of contract and tortious interference with contracts and prospective business relations. *************************************************** With Inyx USA out of action, it is believed that only around four other contract manufacturers in the world have the capability to commercially make and fill HFA devices - US-based Xemplar Pharmaceuticals, 3M and Catalent, (formerly Cardinal Health), along with UK-based Pharmaserve North West (which incidentally just bought an insolvent Inyx UK site partly to gain this new capability). Meanwhile, only GlaxoSmithKline (GSK), Schering-Plough, AstraZeneca and Boehringer Ingelheim, as well as a couple of smaller firms such as SkyePharma, have also developed this new cabability in-house for their own products. Both Kos and King previously tried to develop the process in-house but were unsuccessful and discontinued these efforts long ago. "Any company wanting to move into this area of manufacturing would need at least five years to develop the expertise required. There are also not a lot of trained people in this field and most of those that are work for big pharma companies," Charles Eck, president of Xemplar told In-PharmaTechnologist.com in an earlier interview. **************************************************** source....http://www.in-pharmatechnologist.com/ Inyx Pharma is now under new management, with the entire business, including assets and staff, being sold as a going concern to a company called Pharmaserve North West on September 13. The deal ends months of nervous twitching from all those with a vested interest in the site, from employees, to customers, suppliers and investors. The new owners are said to have bagged a bargain. An industry source told Outsourcing-Pharma.com that there had been four companies placing bids on the site, although this remains unconfirmed by the administrators. 22-Nov-2007 - Recipharm has come to rescue of UK-based Ashton Pharma, which has been nervously awaiting to discover its fate, having spent five months in administration after its former owners Inyx Inc. suffered major financial woes. Outsourcing-Pharma.com has learned that the Swedish contract manufacturing organisation (CMO) bought the troubled firm for an undisclosed sum in a deal that closed late last night. The firm said that the purchase brings additional capacity and capabilities to the group for solid dose, sterile ampoules and vials as well as inhalation technology, as well as "a significant presence in one of Europe's major pharmaceutical markets". Roy Bailey and David Duggins from Ernst & Young (EY) were then appointed by the UK courts as joint administrators to the three companies. At the time they confirmed that "Both facilities are good profitable businesses… and any buyers would take on the assets and employee liabilities, while the administrators would pay off the companies' debts using the money from the sale." CONTRACTS: King and Inyx Establish Ten-Year Co-Marketing Collaboration for King's Intal and Tilade Respiratory Products 08 September 2005 10:50 http://www.pharmaceutical-technology.com When Inyx Inc. bought Aventis' manufacturing facility in Manati, Puerto Rico in 2005, which was subsequently named Inyx USA, it also took over some of Aventis' manufacturing contracts at the site, along with those of two of its existing customers, King Pharmaceuticals and Kos Pharmaceuticals (now owned by Abbott. Both King and Abbott were asked by Outsourcing-Pharma.com to comment, however, they failed to do so before the time of publishing. There has been talk of Abbott being interested in buying the facility, although an Abbott spokesperson previously told Outsourcing-Pharma.com: "We do not comment on rumours". http://www.in-pharmatechnologist.com ********************** FORM 3--- 06/09/2008 DEUTSCHE BANK AG buy to Rajaratnam Raj 6,095,000 shares http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=5727290
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#376   that trading in the securities of the above-listed DHANA 02/22/21 01:13:47 PM
#375   IYXI SEC Suspension because of questions regarding the Renee 02/22/21 09:49:12 AM
#374   3.2m traded @ .01, what's happening? what happen DHANA 02/16/21 06:27:48 PM
#373   1.3m vol at higher price. what's happening? DHANA 02/12/21 07:48:36 PM
#372   $IYXI ,0075, over 4m on the bid at DHANA 01/26/21 04:50:27 PM
#371   Does anyone have any idea if they are troyal 06/05/20 09:37:15 AM
#370   $IYXI: Its 100% buying.... must be a new Development makinezmoney 09/30/19 02:27:51 PM
#369   ya, what's happening? is it just a pump DHANA 09/30/19 02:23:26 PM
#368   $IYXI: Rippppppppppinnnnnnnnn & Roarin...... now at $0.004 makinezmoney 09/30/19 02:22:15 PM
#367   what's next here? Ticker IYXI will go away? or DHANA 02/05/19 12:19:58 PM
#366   Pharma exec convicted of $100 million fraud scheme DHANA 02/05/19 09:22:51 AM
#365   $IYXI : Interesting trading action... 1Million bid by NITE makinezmoney 12/20/18 01:34:39 PM
#364   this runs during this time of the year. DHANA 05/04/18 11:19:03 AM
#363   $IYXI: Now touching $0.0048 makinezmoney 05/04/18 09:30:01 AM
#362   this one ran last year as well, same DHANA 04/30/18 04:13:34 PM
#361   $IYXI: Nice hit at $0.0025....... any time now :) makinezmoney 10/26/17 10:56:51 AM
#360   $IYXI: Drug Play... mover here.... $0.005s are up makinezmoney 10/05/17 10:16:42 AM
#359   $IYXI: Ok... 500k in Volume now makinezmoney 09/01/17 12:06:43 PM
#358   This junk got frontloaded last month, so maybe Zorax 05/06/17 01:53:33 PM
#356   Super Duper low Floater..... Now $0.005 makinezmoney 04/12/17 11:50:21 AM
#355   WOAaahhhhhhh... I see a run coming makinezmoney 04/12/17 11:47:55 AM
#354   250k traded today. who is buying and why? DHANA 01/30/17 10:18:34 PM
#353   3:36 PM ET 09/30/2016 Ex-drug company CEO charged Zorax 10/17/16 12:03:45 AM
#352   3:36 PM ET 09/30/2016 Ex-drug company CEO charged DHANA 09/30/16 11:41:15 PM
#351   CEO Dr. Jack Kachkar is a crook and Zorax 07/25/16 11:41:46 PM
#350   Law360, New York (March 7, 2016, 4:36 PM DHANA 07/03/16 09:29:29 PM
#349   IYXI - $0.0055 x $0.0060 Aduke 10/05/15 12:55:14 PM
#348   8 years and still court case is dragged DHANA 10/02/15 02:48:27 PM
#347   $IYXI recent news/filings stocktrademan 08/26/15 03:26:46 PM
#346   I don't know, but it does look like Zorax 08/26/15 12:22:09 PM
#345   $IYXI was on my list and still missed MrK 08/26/15 11:58:59 AM
#344   runs again today. any update on the court case? DHANA 08/26/15 09:38:59 AM
#343   when will the court case be completed? DHANA 08/17/15 04:49:59 PM
#342   Is this thing still trading? Zorax 08/05/15 09:07:57 PM
#341   ,,,,,,,Naaah wouldn't buy here at all. MONEYMADE 01/16/15 03:50:50 PM
#340   Thanks for the DD guys Vilhelm_Bock_LLC 01/16/15 12:58:22 PM
#339   Thanks Beast! Dave 01/16/15 12:54:41 PM
#338   I know it got to .012 Dave 01/16/15 12:53:07 PM
#337   It hit 0.012 Beastman93 01/16/15 12:52:40 PM
#336   Not in front of my computer, but I Dave 01/16/15 12:52:33 PM
#335   Dave do you know the true High for Vilhelm_Bock_LLC 01/16/15 12:17:52 PM
#334   Someone bought 4,999 shares at that price. By Dave 01/16/15 12:16:34 PM
#333   Why is the day range saying this stock Vilhelm_Bock_LLC 01/16/15 12:09:28 PM
#332   Yep. Pumped then dumped. ellreb 01/16/15 09:52:38 AM
#331   Promo buy 007. Dead already ClearlyStocks 01/16/15 09:35:08 AM
#330   $IYXI @ .012! Estrella 01/16/15 09:35:06 AM
#329   Running today....what's going on here? Caveat Emptor 01/16/15 09:33:50 AM
#328   was stocharts data http://finance.yahoo.com/q/h?s=IYXI+Headlines Penny Roger$ 01/06/15 06:14:54 PM
#327   Nice call Penny Rogers on IYXI it sure Xzibit 01/06/15 05:41:33 PM
#326   IYXI nice Xzibit 01/06/15 05:32:28 PM
Consent Preferences